Engineering antibodies with a novel fusion protein

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to advance research projects.

Even with significant expansion in the global market for antibodies used in clinical care and research, scientists recognize that there is still untapped potential for finding new antibodies. Many proteins group together in what are called protein complexes to carry out…

Continue Reading


News Source: www.sciencedaily.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *